Trial Profile
Rosuvastatin versus Protease Inhibitor Switching for Hypercholesterolaemia in HIV-infected Adults [Rosuvastatina versus sustitucion del Inhibidor de la Proteasa en pacientes adultos con infeccion por el VIH e hipercolesterolemia]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Antivirals; Peptide hydrolase inhibitors; Ritonavir
- Indications HIV infections; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms SoS
- 07 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Sep 2013 Planned end date (Mar 2015) added as reported by ClinicalTrials.gov.
- 09 Sep 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01935674).